Stratasys Releases Second Quarter 2025 Financial Results
-
Revenue of
$138.1 million , compared to$138.0 million in the prior year period -
GAAP net loss of
$16.7 million , or$0.20 per diluted share, and non-GAAP net income of$2.2 million , or$0.03 per diluted share -
Adjusted EBITDA of
$6.1 million , compared to$2.3 million in the prior year period -
$254.6 million cash, equivalents and short-term deposits and no debt atJune 30, 2025 - Updates 2025 Outlook
“Our results once again reflect resilience from our recurring revenue streams and the reliance customers place on our additive manufacturing technologies," commented Dr.
Summary - Second Quarter 2025 Financial Results Compared to Second Quarter 2024:
-
Revenue of
$138.1 million compared to$138.0 million . - GAAP gross margin of 43.1%, compared to 43.8%.
- Non-GAAP gross margin of 47.7%, compared to 49.0%.
-
GAAP operating loss of
$16.6 million , compared to an operating loss of$26.0 million . -
Non-GAAP operating income of
$1.1 million , compared to an operating loss of$3.2 million . -
GAAP net loss of
$16.7 million , or$0.20 per diluted share, compared to a net loss of$25.7 million , or$0.36 per diluted share. -
Non-GAAP net income of
$2.2 million , or$0.03 per diluted share, compared to a net loss of$3.0 million , or$0.04 per diluted share. -
Adjusted EBITDA of
$6.1 million , compared to$2.3 million . -
Cash used in operating activities of
$1.1 million , compared to$2.4 million .
Financial Outlook:
-
Based on current market conditions and assuming that the impacts of tariff policy, global inflationary pressures, relatively high interest rates and supply chain costs do not impede economic activity further, the Company is updating its outlook for 2025 to be as follows:
-
Full year revenue of
$550 million to$560 million .
-
Full year revenue of
- Third quarter slightly lower to slightly higher than second quarter, fourth quarter higher than third quarter.
- Full year non-GAAP gross margins of 46.7% to 47.0%.
-
Full year operating expenses to range from
$248 million to$251 million . - Full year non-GAAP operating margins to range from 1.5% to 2.0%.
-
Adjusted EBITDA ranging from
$30 million to$32 million .- Fourth quarter 2025 Adjusted EBITDA to be 8.0% or more of revenue.
-
Capital expenditures ranging from
$20 million to$25 million . - Positive operating cash flow.
-
GAAP net loss ranging from
$77 million to$66 million , and GAAP EPS of ($0.94 ) to ($0.80 ). -
Non-GAAP net income ranging from
$11 million to$13 million , and Non-GAAP EPS ranging from$0.13 to$0.16 .
Appropriate reconciliations between historical GAAP and non-GAAP financial measures, as well as between the GAAP and non-GAAP financial measures included in our updated financial outlook for 2025, are provided in the tables at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures. We have not included, however, a reconciliation of our guidance for non-GAAP gross margins to the most directly comparable GAAP financial measure, as we are unable to do so without unreasonable effort or with reasonable certainty from a quantitative perspective.
The Company plans to webcast its conference call to discuss its second quarter 2025 financial results on
The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com, or directly at the following web address:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=NkEiLhG2
To participate by telephone, the
To learn more about
Cautionary Statement Regarding Forward-Looking Statements
The statements in this press release regarding
Use of Non-GAAP Financial Measures
The non-GAAP data included herein, but not limited, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations. Our management utilizes these non-GAAP measures to enable us to assess our financial results (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, and legal provisions, (ii) excluding non-cash items such as share-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items, (iii) for certain non-GAAP measures, after eliminating the impact of changes attributable to currency exchange rate fluctuations, and (iv) after excluding changes in revenues solely attributable to divestitures of former subsidiary companies. The items eliminated as part our calculation of our non-GAAP financial measures either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. Our non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in the tables below.
|
|||||||||
Consolidated Balance Sheets | |||||||||
( |
|||||||||
(Unaudited) | |||||||||
|
|
||||||||
ASSETS | |||||||||
Current assets | |||||||||
Cash and cash equivalents |
$ |
71,073 |
|
$ |
70,200 |
|
|||
Short-term bank deposits |
|
183,500 |
|
|
80,500 |
|
|||
Accounts receivable, net of allowance for credit losses of |
|
157,869 |
|
|
152,979 |
|
|||
Inventories |
|
164,585 |
|
|
179,809 |
|
|||
Prepaid expenses |
|
9,481 |
|
|
7,630 |
|
|||
Other current assets |
|
28,338 |
|
|
21,843 |
|
|||
Total current assets |
|
614,846 |
|
|
512,961 |
|
|||
Non-current assets | |||||||||
Property, plant and equipment, net |
|
190,358 |
|
|
184,379 |
|
|||
|
|
101,569 |
|
|
99,082 |
|
|||
Other intangible assets, net |
|
106,013 |
|
|
106,253 |
|
|||
Operating lease right-of-use assets |
|
30,723 |
|
|
32,169 |
|
|||
Long-term investments |
|
79,268 |
|
|
80,205 |
|
|||
Other non-current assets |
|
16,210 |
|
|
14,697 |
|
|||
Total non-current assets |
|
524,141 |
|
|
516,785 |
|
|||
Total assets |
$ |
1,138,987 |
|
$ |
1,029,746 |
|
|||
LIABILITIES AND EQUITY | |||||||||
Current liabilities | |||||||||
Accounts payable |
$ |
38,148 |
|
$ |
44,977 |
|
|||
Accrued expenses and other current liabilities |
|
38,741 |
|
|
39,749 |
|
|||
Accrued compensation and related benefits |
|
30,316 |
|
|
29,206 |
|
|||
Deferred revenues - short-term |
|
51,805 |
|
|
46,347 |
|
|||
Operating lease liabilities - short-term |
|
7,039 |
|
|
6,935 |
|
|||
Total current liabilities |
|
166,049 |
|
|
167,214 |
|
|||
Non-current liabilities | |||||||||
Deferred revenues - long-term |
|
19,752 |
|
|
19,057 |
|
|||
Deferred income taxes |
|
469 |
|
|
507 |
|
|||
Operating lease liabilities - long-term |
|
24,043 |
|
|
25,155 |
|
|||
Contingent consideration - long-term |
|
5,153 |
|
|
4,933 |
|
|||
Other non-current liabilities |
|
21,140 |
|
|
19,889 |
|
|||
Total non-current liabilities |
|
70,557 |
|
|
69,541 |
|
|||
Total liabilities |
$ |
236,606 |
|
$ |
236,755 |
|
|||
Contingencies (see note 12) | |||||||||
Equity | |||||||||
Ordinary shares, |
$ |
238 |
|
$ |
202 |
|
|||
|
|
(1,995 |
) |
|
(1,995 |
) |
|||
Additional paid-in capital |
|
3,260,364 |
|
|
3,123,024 |
|
|||
Accumulated other comprehensive loss |
|
(6,218 |
) |
|
(8,031 |
) |
|||
Accumulated deficit |
|
(2,350,008 |
) |
|
(2,320,209 |
) |
|||
Total equity |
|
902,381 |
|
|
792,991 |
|
|||
Total liabilities and equity |
$ |
1,138,987 |
|
$ |
1,029,746 |
|
|||
|
||||||||||||||||
Consolidated Statements of Operations | ||||||||||||||||
( |
Three Months Ended |
Six Months Ended |
||||||||||||||
(Unaudited) |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
||||
Revenues | ||||||||||||||||
Products |
$ |
94,791 |
|
$ |
93,594 |
|
$ |
188,586 |
|
$ |
192,790 |
|
||||
Services |
|
43,295 |
|
|
44,447 |
|
|
85,546 |
|
|
89,301 |
|
||||
|
138,086 |
|
|
138,041 |
|
|
274,132 |
|
|
282,091 |
|
|||||
Cost of revenues | ||||||||||||||||
Products |
|
48,617 |
|
|
46,756 |
|
|
95,885 |
|
|
96,513 |
|
||||
Services |
|
29,975 |
|
|
30,785 |
|
|
58,514 |
|
|
61,181 |
|
||||
|
78,592 |
|
|
77,541 |
|
|
154,399 |
|
|
157,694 |
|
|||||
Gross profit |
|
59,494 |
|
|
60,500 |
|
|
119,733 |
|
|
124,397 |
|
||||
Operating expenses | ||||||||||||||||
Research and development, net |
|
19,921 |
|
|
25,680 |
|
|
38,713 |
|
|
49,657 |
|
||||
Selling, general and administrative |
|
56,193 |
|
|
60,863 |
|
|
110,044 |
|
|
125,236 |
|
||||
|
76,114 |
|
|
86,543 |
|
|
148,757 |
|
|
174,893 |
|
|||||
Operating loss |
|
(16,620 |
) |
|
(26,043 |
) |
|
(29,024 |
) |
|
(50,496 |
) |
||||
Financial income (expenses), net |
|
3,286 |
|
|
(726 |
) |
|
4,759 |
|
|
491 |
|
||||
loss before income taxes |
|
(13,334 |
) |
|
(26,769 |
) |
|
(24,265 |
) |
|
(50,005 |
) |
||||
Income tax expenses |
|
1,041 |
|
|
762 |
|
|
1,496 |
|
|
1,478 |
|
||||
Share in profits (losses) of associated companies |
|
(2,370 |
) |
|
1,788 |
|
|
(4,038 |
) |
|
(243 |
) |
||||
Net loss |
$ |
(16,745 |
) |
$ |
(25,743 |
) |
$ |
(29,799 |
) |
$ |
(51,726 |
) |
||||
Net loss per ordinary share - basic and diluted |
$ |
(0.20 |
) |
$ |
(0.36 |
) |
$ |
(0.38 |
) |
$ |
(0.74 |
) |
||||
Weighted average ordinary shares outstanding - basic and diluted |
|
83,485 |
|
|
70,746 |
|
|
77,722 |
|
|
70,367 |
|
|
|||||||||||||||||||||||
Reconciliation of GAAP to Non-GAAP Results of Operations | |||||||||||||||||||||||
Three Months Ended |
|||||||||||||||||||||||
|
2025 |
|
Non-GAAP |
|
2025 |
|
2024 |
|
Non-GAAP |
|
2024 |
|
|||||||||||
GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | ||||||||||||||||||
|
|||||||||||||||||||||||
Gross profit (1) |
$ |
59,494 |
|
$ |
6,323 |
|
$ |
65,817 |
$ |
60,500 |
|
$ |
7,175 |
|
$ |
67,675 |
|
||||||
Operating income (loss) (1,2) |
|
(16,620 |
) |
|
17,736 |
|
|
1,116 |
|
(26,043 |
) |
|
22,845 |
|
|
(3,198 |
) |
||||||
Net income (loss) (1,2,3) |
|
(16,745 |
) |
|
18,925 |
|
|
2,180 |
|
(25,743 |
) |
|
22,774 |
|
|
(2,969 |
) |
||||||
Net income (loss) per diluted share (4) |
$ |
(0.20 |
) |
$ |
0.23 |
|
$ |
0.03 |
$ |
(0.36 |
) |
$ |
0.32 |
|
$ |
(0.04 |
) |
||||||
(1) |
Acquired intangible assets amortization expenses |
|
4,517 |
|
|
4,489 |
|
||||||||||||||||
Non-cash share-based compensation expenses |
|
746 |
|
|
1,010 |
|
|||||||||||||||||
Restructuring and other expenses |
|
1,060 |
|
|
1,676 |
|
|||||||||||||||||
|
6,323 |
|
|
7,175 |
|
||||||||||||||||||
(2) |
Acquired intangible assets amortization expenses |
|
915 |
|
|
1,111 |
|
||||||||||||||||
Non-cash share-based compensation expenses |
|
5,392 |
|
|
6,335 |
|
|||||||||||||||||
Restructuring and other related costs |
|
460 |
|
|
3,639 |
|
|||||||||||||||||
Contingent consideration |
|
643 |
|
|
523 |
|
|||||||||||||||||
Legal and other expenses |
|
4,003 |
|
|
4,062 |
|
|||||||||||||||||
|
11,413 |
|
|
15,670 |
|
||||||||||||||||||
|
17,736 |
|
|
22,845 |
|
||||||||||||||||||
(3) |
Corresponding tax effect |
|
182 |
|
|
204 |
|
||||||||||||||||
Equity method related expenses (income) |
|
1,067 |
|
|
(1,593 |
) |
|||||||||||||||||
Finance expenses (income) |
|
(60 |
) |
|
1,318 |
|
|||||||||||||||||
$ |
18,925 |
|
$ |
22,774 |
|
||||||||||||||||||
(4) |
Weighted average number of ordinary shares outstanding - Diluted |
|
83,485 |
|
|
84,024 |
|
70,746 |
|
|
70,746 |
|
|
|||||||||||||||||||||||
Reconciliation of GAAP to Non-GAAP Results of Operations | |||||||||||||||||||||||
Six Months Ended |
|||||||||||||||||||||||
|
2025 |
|
Non-GAAP |
|
2025 |
|
2024 |
|
Non-GAAP |
|
2024 |
|
|||||||||||
GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | ||||||||||||||||||
|
|||||||||||||||||||||||
Gross profit (1) |
$ |
119,733 |
|
$ |
11,733 |
|
$ |
131,466 |
$ |
124,397 |
|
$ |
13,314 |
|
$ |
137,711 |
|
||||||
Operating income (loss) (1,2) |
|
(29,024 |
) |
|
33,186 |
|
|
4,162 |
|
(50,496 |
) |
|
46,099 |
|
|
(4,397 |
) |
||||||
Net income (loss) (1,2,3) |
|
(29,799 |
) |
|
34,857 |
|
|
5,058 |
|
(51,726 |
) |
|
47,073 |
|
|
(4,653 |
) |
||||||
Net income (loss) per diluted share (4) |
$ |
(0.38 |
) |
$ |
0.44 |
|
$ |
0.06 |
$ |
(0.74 |
) |
$ |
0.67 |
|
$ |
(0.07 |
) |
||||||
(1) |
Acquired intangible assets amortization expenses |
|
9,005 |
|
|
9,573 |
|
||||||||||||||||
Non-cash share-based compensation expenses |
|
1,454 |
|
|
1,962 |
|
|||||||||||||||||
Restructuring and other expenses |
|
1,274 |
|
|
1,779 |
|
|||||||||||||||||
|
11,733 |
|
|
13,314 |
|
||||||||||||||||||
(2) |
Acquired intangible assets amortization expenses |
|
1,855 |
|
|
3,570 |
|
||||||||||||||||
Non-cash share-based compensation expenses |
|
10,897 |
|
|
14,032 |
|
|||||||||||||||||
Restructuring and other related costs |
|
1,592 |
|
|
4,559 |
|
|||||||||||||||||
Revaluation of investment |
|
- |
|
|
1,900 |
|
|||||||||||||||||
Contingent consideration |
|
1,288 |
|
|
1,034 |
|
|||||||||||||||||
Legal and other expenses |
|
5,821 |
|
|
7,690 |
|
|||||||||||||||||
|
21,453 |
|
|
32,785 |
|
||||||||||||||||||
|
33,186 |
|
|
46,099 |
|
||||||||||||||||||
(3) |
Corresponding tax effect |
|
266 |
|
|
438 |
|
||||||||||||||||
Equity method related expenses (income) |
|
1,908 |
|
|
(629 |
) |
|||||||||||||||||
Finance expenses (income) |
|
(503 |
) |
|
1,165 |
|
|||||||||||||||||
$ |
34,857 |
|
$ |
47,073 |
|
||||||||||||||||||
(4) |
Weighted average number of ordinary shares outstanding - Diluted |
|
77,722 |
|
|
78,321 |
|
70,367 |
|
|
70,367 |
|
|
||||||||||||||
Reconciliation of GAAP net loss to Adjusted EBITDA | ||||||||||||||
Three months ended |
Six months ended |
|||||||||||||
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
|||
|
|
|||||||||||||
Net loss |
$ |
(16,745 |
) |
$ |
(25,743 |
) |
$ |
(29,799 |
) |
$ |
(51,726 |
) |
||
Financial expenses (income), net |
|
(3,286 |
) |
|
726 |
|
|
(4,759 |
) |
|
(491 |
) |
||
Income tax expenses |
|
1,041 |
|
|
762 |
|
|
1,496 |
|
|
1,478 |
|
||
Share in losses (profits) of associated companies |
|
2,370 |
|
|
(1,788 |
) |
|
4,038 |
|
|
243 |
|
||
Depreciation expenses |
|
5,129 |
|
|
5,482 |
|
|
10,463 |
|
|
10,787 |
|
||
Amortization expenses |
|
5,442 |
|
|
5,600 |
|
|
10,879 |
|
|
13,143 |
|
||
Non-cash share-based compensation expenses |
|
6,138 |
|
|
7,345 |
|
|
12,351 |
|
|
15,994 |
|
||
Revaluation of investment |
|
- |
|
|
- |
|
|
- |
|
|
1,900 |
|
||
Contingent consideration |
|
643 |
|
|
523 |
|
|
1,288 |
|
|
1,034 |
|
||
Legal and other expenses |
|
3,878 |
|
|
4,062 |
|
|
5,554 |
|
|
7,690 |
|
||
Restructuring and other expenses |
|
1,519 |
|
|
5,315 |
|
|
2,788 |
|
|
6,338 |
|
||
Adjusted EBITDA |
$ |
6,129 |
|
$ |
2,284 |
|
$ |
14,299 |
|
$ |
6,390 |
|
||
|
||||
Reconciliation of GAAP Net Loss to Non-GAAP Net Income Forward Looking Guidance: | ||||
Fiscal Year 2025 | ||||
( |
|
|||
GAAP net loss |
|
|||
Adjustments | ||||
Share-based compensation expenses |
|
|||
Intangible assets amortization expenses |
|
|||
Reorganization and other |
|
|||
Tax expenses related to Non-GAAP adjustments |
|
|||
Non-GAAP net income |
|
|||
GAAP loss per share |
|
|||
Non-GAAP diluted earnings per share |
|
|||
Reconciliation of GAAP Net Loss to Adjusted EBITDA Forward Looking Guidance: | ||||
Fiscal Year 2025 | ||||
( |
|
|||
GAAP net loss |
|
|||
Adjustments | ||||
Share-based compensation expenses |
|
|||
Intangible assets amortization expenses |
|
|||
Reorganization and other |
|
|||
Tax expenses related to Non-GAAP adjustments |
|
|||
Other non-operating income |
|
|||
Depreciation |
|
|||
Adjusted EBITDA |
|
|||
|
||||
Reconciliation of GAAP Operating Loss to Non-GAAP Operating Income Forward Looking Guidance: | ||||
Fiscal Year 2025 | ||||
( |
|
|||
GAAP operating loss |
|
|||
GAAP operating margins | (13%) to (11%) | |||
Adjustments | ||||
Share-based compensation expenses |
|
|||
Intangible assets amortization expenses |
|
|||
Reorganization and other |
|
|||
Non-GAAP operating profit |
|
|||
Non-GAAP operating margins | 1.5 % to 2.0% | |||
View source version on businesswire.com: https://www.businesswire.com/news/home/20250813229731/en/
CCO & VP Investor Relations
Yonah.Lloyd@stratasys.com
Source: